Chen M - Search Results

1

The effect of transition timing of regorafenib on treatment outcomes in unresectable hepatocellular carcinoma: a real-world study.

Hu L, Yang Z, Yang Z, Peng W, Tang X, Ye Z, Wang J, Fu Y, Hu D, Chen M, Zhang Y, Chen J. Hu L, et al. Among authors: chen j, chen m. Hepatol Int. 2024 Dec 2. doi: 10.1007/s12072-024-10757-4. Online ahead of print. Hepatol Int. 2024. PMID: 39621230

2

Efficacy of additional locoregional therapy based on systemic therapy after intrahepatic progression for BCLC stage B/C hepatocellular carcinoma: A real-world study.

Hu Z, Hu Z, Zhan W, Wu W, Zhou Z, Chen M, Fu Y, Zhang Y. Hu Z, et al. Among authors: chen m. Int Immunopharmacol. 2024 Jan 25;127:111413. doi: 10.1016/j.intimp.2023.111413. Epub 2023 Dec 19. Int Immunopharmacol. 2024. PMID: 38118318

3

Lenvatinib, Toripalimab plus FOLFOX Chemotherapy in Hepatocellular Carcinoma Patients with Extrahepatic Metastasis: A Biomolecular Exploratory, Phase II Trial (LTSC).

He M, Huang Y, Du Z, Lai Z, Ouyang H, Shen J, Wen D, Li Q, Zhang Y, Wei W, Chen M, Xu L, Kan A, Shi M. He M, et al. Among authors: chen m. Clin Cancer Res. 2023 Dec 15;29(24):5104-5115. doi: 10.1158/1078-0432.CCR-23-0060. Clin Cancer Res. 2023. PMID: 37819944 Clinical Trial.

4

APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024.

Lau G, Obi S, Zhou J, Tateishi R, Qin S, Zhao H, Otsuka M, Ogasawara S, George J, Chow PKH, Cai J, Shiina S, Kato N, Yokosuka O, Oura K, Yau T, Chan SL, Kuang M, Ueno Y, Chen M, Cheng AL, Cheng G, Chuang WL, Baatarkhuu O, Bi F, Dan YY, Gani RA, Tanaka A, Jafri W, Jia JD, Kao JH, Hasegawa K, Lau P, Lee JM, Liang J, Liu Z, Lu Y, Pan H, Payawal DA, Rahman S, Seong J, Shen F, Shiha G, Song T, Sun HC, Masaki T, Sirachainan E, Wei L, Yang JM, Sallano JD, Zhang Y, Tanwandee T, Dokmeci A, Zheng SS, Fan J, Fan ST, Sarin SK, Omata M. Lau G, et al. Among authors: chen m. Hepatol Int. 2024 Dec;18(6):1661-1683. doi: 10.1007/s12072-024-10732-z. Epub 2024 Nov 21. Hepatol Int. 2024. PMID: 39570557

5

Improving the Conversion Success Rate of Hepatocellular Carcinoma: Focus on the Use of Combination Therapy with a High Objective Response Rate.

Chen QF, Chen S, Chen M, Lyu N, Zhao M. Chen QF, et al. Among authors: chen m, chen s. J Clin Transl Hepatol. 2024 Mar 28;12(3):298-304. doi: 10.14218/JCTH.2023.00403. Epub 2024 Jan 10. J Clin Transl Hepatol. 2024. PMID: 38426191 Free PMC article. Review.

6

Effectiveness of lenvatinib plus immune checkpoint inhibitors in primary advanced hepatocellular carcinoma beyond oligometastasis.

Wang XH, Liu CJ, Wen HQ, Duan XH, Jiao YQ, Liu YJ, Chen MS, Zhu KS, Mao XH, Zhou QF. Wang XH, et al. Clin Transl Med. 2023 Mar;13(3):e1214. doi: 10.1002/ctm2.1214. Clin Transl Med. 2023. PMID: 36855781 Free PMC article.

7

Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial.

Qin S, Chen M, Cheng AL, Kaseb AO, Kudo M, Lee HC, Yopp AC, Zhou J, Wang L, Wen X, Heo J, Tak WY, Nakamura S, Numata K, Uguen T, Hsiehchen D, Cha E, Hack SP, Lian Q, Ma N, Spahn JH, Wang Y, Wu C, Chow PKH; IMbrave050 investigators. Qin S, et al. Among authors: chen m. Lancet. 2023 Nov 18;402(10415):1835-1847. doi: 10.1016/S0140-6736(23)01796-8. Epub 2023 Oct 20. Lancet. 2023. PMID: 37871608 Clinical Trial.

8

The Prevalence of Irritable Bowel Syndrome after Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Their Association: A Systematic Review and Meta-Analysis of Observational Studies.

Wang Z, Peng Y, Chen M, Peng L, Huang Y, Lin W. Wang Z, et al. Among authors: chen m. J Clin Med. 2023 Feb 27;12(5):1865. doi: 10.3390/jcm12051865. J Clin Med. 2023. PMID: 36902651 Free PMC article. Review.

9

The Global Kidney Patient Trials Network and the CAPTIVATE Platform Clinical Trial Design: A Trial Protocol.

Kotwal SS, Perkovic V, Jardine MJ, Kim D, Shah NA, Lin E, Coggan S, Billot L, Vart P, Wheeler DC, de Boer IH, Zhang H, Hou FF, Sugawara Y, Marion J, Lewis RJ, Berry LR, McGlothlin A, Jha V, De Nicola L, Gorriz JL, Heerspink HJL; GKPTN and CAPTIVATE Investigators. Kotwal SS, et al. JAMA Netw Open. 2024 Dec 2;7(12):e2449998. doi: 10.1001/jamanetworkopen.2024.49998. JAMA Netw Open. 2024. PMID: 39661388 Clinical Trial.

10

Reply to Araújo: Good science requires focus.

Sethi SS, Bick A, Chen MY, Crouzeilles R, Hillier BV, Lawson J, Lee CY, Liu SH, Parruco CHF, Rosten CM, Somveille M, Tuanmu MN, Banks-Leite C. Sethi SS, et al. Among authors: chen my. Proc Natl Acad Sci U S A. 2024 Dec 17;121(51):e2420476121. doi: 10.1073/pnas.2420476121. Epub 2024 Dec 11. Proc Natl Acad Sci U S A. 2024. PMID: 39661057 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

50,770 results

Search Page

Filters